The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

FDA Approves KEYTRUDA® (pembrolizumab) for PD-L1+ Resectable Locally Advanced Head & Neck Squamous Cell Carcinoma as Neoadjuvant Treatment, Continued as Adjuvant Treatment Combined With ...

An experiment involving artificial organs is just one way researchers are trying to capitalize on the weird ways low-gravity ...

RAHWAY, N.J., June 13, 2025--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA® ...

CHICAGO — First-line treatment with sacituzumab govitecan plus pembrolizumab showed significant improvement in PFS vs. chemotherapy plus pembrolizumab among patients with metastatic triple ...

Sentinel lymph node biopsy versus pelvic lymphadenectomy in cervical cancer: The PHENIX trial. FIRST/ENGOT-OV44: A phase 3 clinical trial of dostarlimab (dost) and niraparib (nira) in first-line (1L) ...

Alvotech (ALVO) and Dr. Reddy’s Laboratories (RDY) have entered into a collaboration and license agreement to co-develop, manufacture, and commercialize a biosimilar candidate to Keytruda ...

Pts were randomized in a 2:1 ratio to receive either benmelstobart plus anlotinib (benmel+ anlo) or pembrolizumab plus placebo (pem+placebo). Anlotinib or placebo was administered orally at a dose of ...

Regeneron Pharmaceuticals, Inc. faces challenges with Eylea sales but sees growth from Dupixent and obesity drugs. Click for ...

CHICAGO — Pittsburgh Pirates catcher Endy Rodríguez is going to get a platelet-rich plasma injection for his ailing right elbow. Rodríguez got a second opinion from Dodgers team physician Dr ...

New York Yankees closer Luke Weaver received a platelet-rich plasma injection designed to speed healing in his injured left hamstring, according to the Associated Press (h/t ESPN).

Keytruda® (pembrolizumab) is indicated for the treatment of numerous cancer types. In 2024, worldwide sales of Keytruda were US$29.5 billion [1].